BridgeBio Pharma Inc (NASDAQ:BBIO)
| 31.94 Delayed Data As of Dec 04 |  +1.00 / +3.23%Today’s Change | 6.64 Today|||52-Week Range 36.36 | +319.16% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Viking Global Investors Lp |  Sale | 7/18/2023 | 1,500,000 | $35.00 | $52.5M | -1.78% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 4/05/2023 | 120,000 | $15.46 | $1.9M | +105.67% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 5/03/2023 | 120,000 | $14.18 | $1.7M | +121.81% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 8/16/2023 | 50,698 | $29.80 | $1.5M | +7.18% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 11/17/2023 | 51,352 | $29.10 | $1.5M | +9.20% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 8/17/2023 | 51,552 | $28.59 | $1.5M | +12.43% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 11/16/2023 | 50,697 | $28.86 | $1.5M | +10.67% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 2/03/2023 | 120,000 | $11.01 | $1.3M | +194.11% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 3/03/2023 | 120,000 | $10.96 | $1.3M | +193.84% |
Stephenson Brian C Chief Financial Officer & Secretary | Sale | 5/03/2023 | 64,929 | $14.18 | $920.7K | +121.81% |
Page of 6